Skip to main content
Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.43
-0.04 (-0.14%)
At close: Apr 28, 2026, 4:00 PM EDT
28.42
-0.01 (-0.04%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Galapagos NV Revenue

In the year 2025, Galapagos NV had annual revenue of 1.11B EUR with 303.50% growth. Galapagos NV had revenue of 900.82M in the quarter ending December 31, 2025.

Revenue (ttm)
1.11B EUR
Revenue Growth
+303.50%
P/S Ratio
1.43
Revenue / Employee
1,993,276 EUR
Employees
558
Market Cap
1.87B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.11B836.60M303.50%
Dec 31, 2024275.65M35.93M14.99%
Dec 31, 2023239.72M-1.53M-0.63%
Dec 31, 2022241.25M6.87M2.93%
Dec 31, 2021234.38M-243.67M-50.97%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 868.45M
Vericel 276.26M
AnaptysBio 234.60M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Mesoblast 65.38M
Capricor Therapeutics 11.13M
Taysha Gene Therapies 9.77M
Revenue Rankings

GLPG News

More News